Medicinal cannabis products producer ECS Botanics (ASX: ECS) has struck an exclusive distribution deal with California-based Terphogz LLC, paving the…
As of early 2023, over three million Aussies aged 14 and above were found to either smoke or vape. With…
B2B pharmaceutical company and medical cannabis cultivator ECS Botanics (ASX: ECS) has secured an offtake agreement to supply medical cannabis…
The budding cannabis market in New Zealand continues to flourish as more Kiwis seek an alternative to standard pharmaceutical drugs.…
Medicinal cannabis company ECS Botanics (ASX: ECS) is quickly growing its international sales pipeline following their acquisition of Murray Meds…
Australians keen to capitalise on the nutritional benefits around hemp will soon be able to do so via soup formats…